BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29464358)

  • 1. Association of cystatin C- and creatinine-based eGFR with osteoporotic fracture in Japanese postmenopausal women with osteoporosis: sarcopenia as risk for fracture.
    Kurajoh M; Inaba M; Nagata Y; Yamada S; Imanishi Y; Emoto M
    J Bone Miner Metab; 2019 Mar; 37(2):282-291. PubMed ID: 29464358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure.
    Chen DC; Shlipak MG; Scherzer R; Bansal N; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
    Am J Kidney Dis; 2022 Dec; 80(6):762-772.e1. PubMed ID: 35817274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated GFR and risk of hip fracture in older men: comparison of associations using cystatin C and creatinine.
    Ensrud KE; Parimi N; Fink HA; Ishani A; Taylor BC; Steffes M; Cauley JA; Lewis CE; Orwoll ES;
    Am J Kidney Dis; 2014 Jan; 63(1):31-9. PubMed ID: 23890927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraindividual difference in estimated GFR by creatinine and cystatin C, cognitive trajectories and motoric cognitive risk syndrome.
    Wang J; Liu Y; Jin R; Zhao X; Wu Z; Han Z; Xu Z; Guo X; Tao L
    Nephrol Dial Transplant; 2024 Apr; 39(5):860-872. PubMed ID: 37930847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discordance Between Creatinine-Based and Cystatin C-Based Estimated GFR: Interpretation According to Performance Compared to Measured GFR.
    Wang Y; Adingwupu OM; Shlipak MG; Doria A; Estrella MM; Froissart M; Gudnason V; Grubb A; Kalil R; Mauer M; Rossing P; Seegmiller J; Coresh J; Levey AS; Inker LA
    Kidney Med; 2023 Oct; 5(10):100710. PubMed ID: 37753251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication-Related Adverse Events and Discordancies in Cystatin C-Based vs Serum Creatinine-Based Estimated Glomerular Filtration Rate in Patients With Cancer.
    Hanna PE; Wang Q; Strohbehn IA; Moreno D; Harden D; Ouyang T; Katz-Agranov N; Seethapathy H; Reynolds KL; Gupta S; Leaf DE; Sise ME
    JAMA Netw Open; 2023 Jul; 6(7):e2321715. PubMed ID: 37405775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women.
    Driver TH; Scherzer R; Peralta CA; Tien PC; Estrella MM; Parikh CR; Butch AW; Anastos K; Cohen MH; Nowicki M; Sharma A; Young MA; Abraham A; Shlipak MG
    AIDS; 2013 Sep; 27(14):2291-9. PubMed ID: 23669156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancies between Cystatin C-Based and Creatinine-Based eGFR.
    Farrington DK; Surapaneni A; Matsushita K; Seegmiller JC; Coresh J; Grams ME
    Clin J Am Soc Nephrol; 2023 Sep; 18(9):1143-1152. PubMed ID: 37339177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association of Intraindividual Difference Between Cystatin- and Creatinine-Based Estimated GFR and Contrast-Associated Acute Kidney Injury.
    Zhang LW; Luo MQ; Zeng JL; You ZB; Chen LC; Chen JH; Lin KY; Guo YS
    Clin Interv Aging; 2024; 19():411-420. PubMed ID: 38476830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin C- and Creatinine-based Estimated GFR Differences: Prevalence and Predictors in the UK Biobank.
    Chen DC; Lu K; Scherzer R; Lees JS; Rutherford E; Mark PB; Potok OA; Rifkin DE; Ix JH; Shlipak MG; Estrella MM
    Kidney Med; 2024 Apr; 6(4):100796. PubMed ID: 38567244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive effect of estimated glomerular filtrate rate by creatinine or cystatin C on mortality in patients with coronary artery disease.
    Chen S; Zhou Y; Liang G; Wu W; Huang Z; Shi L; Gao Y; Gu X; Wang D
    Ren Fail; 2024 Dec; 46(1):2327494. PubMed ID: 38566467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordances Between Creatinine- and Cystatin C-Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice.
    Carrero JJ; Fu EL; Sang Y; Ballew S; Evans M; Elinder CG; Barany P; Inker LA; Levey AS; Coresh J; Grams ME
    Am J Kidney Dis; 2023 Nov; 82(5):534-542. PubMed ID: 37354936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Cystatin C Level for Risk Stratification in Adults With Chronic Kidney Disease.
    Lees JS; Rutherford E; Stevens KI; Chen DC; Scherzer R; Estrella MM; Sullivan MK; Ebert N; Mark PB; Shlipak MG
    JAMA Netw Open; 2022 Oct; 5(10):e2238300. PubMed ID: 36282503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GFR estimated with creatinine rather than cystatin C is more reflective of the true risk of adverse outcomes with low GFR in kidney transplant recipients.
    Keddis MT; Howard MR; Galapia L; Barreto EF; Zhang N; Butterfield RJ; Rule AD
    Nephrol Dial Transplant; 2023 Jul; 38(8):1898-1906. PubMed ID: 36646435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia, adiposity and large discordance between cystatin C and creatinine-based estimated glomerular filtration rate in patients with cancer.
    Hanna PE; Ouyang T; Tahir I; Katz-Agranov N; Wang Q; Mantz L; Strohbehn I; Moreno D; Harden D; Dinulos JE; Cosar D; Seethapathy H; Gainor JF; Shah SJ; Gupta S; Leaf DE; Fintelmann FJ; Sise ME
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1187-1198. PubMed ID: 38646842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of Association of Cystatin C With Kidney and Cardiovascular Outcomes by Obesity.
    Chen DC; Scherzer R; Ix JH; Kramer HJ; Crews DC; Nadkarni G; Gutierrez O; Bullen AL; Ilori T; Garimella PS; Shlipak MG; Estrella MM
    Am J Kidney Dis; 2024 Apr; 83(4):489-496.e1. PubMed ID: 37866793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) Study.
    Ballew SH; Chen Y; Daya NR; Godino JG; Windham BG; McAdams-DeMarco M; Coresh J; Selvin E; Grams ME
    Am J Kidney Dis; 2017 Feb; 69(2):228-236. PubMed ID: 27884475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin C as a GFR Estimation Marker in Acute and Chronic Illness: A Systematic Review.
    Adingwupu OM; Barbosa ER; Palevsky PM; Vassalotti JA; Levey AS; Inker LA
    Kidney Med; 2023 Dec; 5(12):100727. PubMed ID: 37928862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin C- and Creatinine-Based Estimates of Glomerular Filtration Rate in Dapagliflozin Phase 3 Clinical Trials.
    Mende C; Katz A
    Diabetes Ther; 2016 Mar; 7(1):139-51. PubMed ID: 26899432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cystatin C to inform metformin eligibility among adult veterans with diabetes.
    Tuot DS; Scherzer R; Leong H; Hung AM; Grunfeld C; Shlipak MG
    J Clin Transl Endocrinol; 2016 Mar; 3():1-6. PubMed ID: 28603691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.